R R - American Society of Gene & Cell Therapy

More documents

Recommendations

Info

The American Society of Gene Therapy’s 2004 7th Annual Meeting final program Friday, June 4 SS311 - Cardiovascular: Cell and Gene Therapy for Heart Failure Room: Auditorium Room 1 Chair Todd K. Rosengart, MD Speakers Todd K. Rosengart, MD - Combined Gene and Cell Therapy fro Treating Heart Disease Barry J. Byrne, MD, PhD - Approaches to Cardiac Hypertrophy Using AAV Vectors Frank J. Giordano, MD - Gene Regulation by Engineered Transcription Factor to Augment Cardiac Function SS312 - Embryonic Stem Cells & Tissue Engineering Room: 205 A-D Chair Mervin Yoder, MD Speakers George Q. Daley, MD, PhD - Modeling Hematopoietic Transplantation with ES Cells Lorenz Studer, MD - Human Embryonic Stem Cells and Therapeutic Cloning in Neural Disease Jennifer L. West, PhD - Biomimetic Strategies in Vascular Tissue Engineering SS313 - Genetic Diseases: Gene Therapy for Genetic Disease Using Non-Replacement Strategies Room: 208 A-D Chair Mark A. Kay, MD, PhD Speakers Dieter Gruenert, PhD - Sequence-Specific Modification of Genomic DNA with Fragments of DNA Beverly L. Davidson, PhD - RNAi for Dominant Neurogenetic Diseases Ronald G. Crystal, MD - Correction of Genetic Disorders at the Pre-mRNA Level by Spliceosomemediated Trans-splicing Christopher Walsh, MD, PhD - RNA Trans-Splicing and Genetic Correction SS314 - Musculo-Skeletal: New Approaches to Therapy of Musculo-Skeletal Diseases Room: 211 A-D Chair Michael Themis, PhD Speakers David W. Russell, MD, PhD - Collagen Gene Targeting in Mesenchymal Stem Cells from Individuals with Osteogenesis Imperfecta Michael Themis, PhD - The Fetal Approach: A Novel Therapy for the Treatment of Musculo-Skeletal Disease Josephine Nalbantoglu, PhD - Dystrophin Gene Transfer Terence A. Partridge, PhD - Production of Dystrophin Protein in the Muscles of the MDX Mouse Induced by Local and Systemic Injection of Antisense Oligonucleotides SS315 - Special: Young Investigators Symposium Room: 200 Chair Malcolm Brenner, MD, PhD Speakers Michael A. Barry, PhD - Cell-Targeting Technologies for Gene Therapy Introduced by Arthur Beaudet, MD Laurence JN Cooper, MD, PhD - T-Cell Therapy for Malignant B Cells Introduced by John Zaia, MD Matthew Weitzman, PhD - Lessons from the Battleground of Virus - Host Interactions Introduced by Inder Verma, PhD 41
– The American Society of Gene Therapy’s 2004 7th Annual Meeting final program Friday, June 4 Meet-the-Investigator Sessions 12:30 pm – 1:30 pm The Meet-the-Investigator sessions are designed to provide an opportunity for participants to interact with investigators and discuss topics related to their research. A lunch will be served during the program, which will begin at 12:30 pm and last for approximately one hour. The Meet-the-Investigator sessions require tickets for admission. Tickets for these sessions are not included in the regular registration fees to attend the meeting. Ushers will be collecting tickets at the door of each session. Tickets are available at the registration desk. Please note that space is limited. MI320- In Vivo Therapy with Stabilized Compacted DNA Room: L100 A Pamela Davis, MD, PhD MI321 – Immune Responses to Gene Therapy: The Final Frontier Room: L100 B Pedro Lowenstein, MD, PhD MI322 – Foamy Virus Vectors Room: L100 C David W. Russell, MD, PhD MI323 - Do You Really Want to Know What The FDA Thinks When They Say… Room: L100 D Stephanie Simek, PhD MI324 – Cancer Gene Therapy Room: L100 E Savio L.C. Woo, PhD Simultaneous Oral Presentations 1:45 pm – 4:15 pm OA330 – RNA Virus Vectors: New Technologies Room: 205 A-D Moderators Michael Bitzer, MD, PhD Richard G. Vile, PhD (Abstracts #327 - #336) OA331 – AAV Vectors: Serotypes and Applications Room: 211 A-D Moderators Joseph Rabinowitz, PhD Arun Srivastava, PhD (Abstracts #337 - #346) OA332 – Cancer Immunotherapy Room: 208 A-D Moderators Catherine M. Bollard, MD Michael Jensen, MD (Abstracts #347 - #356) OA333 – Molecular Conjugates Room: Auditorium Room 1 Moderators Theresa Reineke, PhD David V. Schaffer, PhD (Abstracts #357 - #365) OA334 – Infectious Diseases and Vaccines Room: Auditorium Room 3 Moderators Philip Johnson, MD Carl June, MD (Abstracts #366 - #375) OA335 – Gene Therapy for Musculoskeletal Diseases Room: 103 A-C Moderators Steve Ghivizzani, PhD Johnny Huard, PhD (Abstracts #376 - #385) OA336 – Cardiovascular Gene Therapy Room: 102 A-C Moderators J. Kevin Donahue, MD Douglas Losordo, MD (Abstracts #386 - #395) 42
Page 1 and 2: The American Society of Gene Therap
Page 41: The American Society of Gene Therap
Page 93 and 94:
The American Society of Gene Therap
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157:
show all

R R - American Society of Gene & Cell Therapy

Create successful ePaper yourself

Delete template?

Save as template?